Literature DB >> 16029020

Polypeptide point modifications with fatty acid and amphiphilic block copolymers for enhanced brain delivery.

Elena V Batrakova1, Serguei V Vinogradov, Sandra M Robinson, Michael L Niehoff, William A Banks, Alexander V Kabanov.   

Abstract

There is a tremendous need to enhance delivery of therapeutic polypeptides to the brain to treat disorders of the central nervous system (CNS). The brain delivery of many polypeptides is severely restricted by the blood-brain barrier (BBB). The present study demonstrates that point modifications of a BBB-impermeable polypeptide, horseradish peroxidase (HRP), with lipophilic (stearoyl) or amphiphilic (Pluronic block copolymer) moieties considerably enhance the transport of this polypeptide across the BBB and accumulation of the polypeptide in the brain in vitro and in vivo. The enzymatic activity of the HRP was preserved after the transport. The modifications of the HRP with amphiphilic block copolymer moieties through degradable disulfide links resulted in the most effective transport of the HRP across in vitro brain microvessel endothelial cell monolayers and efficient delivery of HRP to the brain. Stearoyl modification of HRP improved its penetration by about 60% but also increased the clearance from blood. Pluronic modification using increased penetration of the BBB and had no significant effect on clearance so that uptake by brain was almost doubled. These results show that point modification can improve delivery of even highly impermeable polypeptides to the brain.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16029020      PMCID: PMC2711208          DOI: 10.1021/bc049730c

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  27 in total

1.  An improved 2,4,6-trinitrobenzenesulfonic acid method for the determination of amines.

Authors:  S L Snyder; P Z Sobocinski
Journal:  Anal Biochem       Date:  1975-03       Impact factor: 3.365

2.  Transformation of water-soluble enzymes into membrane active form by chemical modification.

Authors:  A V Kabanov; A V Levashov; K Martinek
Journal:  Ann N Y Acad Sci       Date:  1987       Impact factor: 5.691

3.  Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data.

Authors:  C S Patlak; R G Blasberg; J D Fenstermacher
Journal:  J Cereb Blood Flow Metab       Date:  1983-03       Impact factor: 6.200

4.  Evaluation of polyether-polyethyleneimine graft copolymers as gene transfer agents.

Authors:  H K Nguyen; P Lemieux; S V Vinogradov; C L Gebhart; N Guérin; G Paradis; T K Bronich; V Y Alakhov; A V Kabanov
Journal:  Gene Ther       Date:  2000-01       Impact factor: 5.250

5.  Impaired transport of leptin across the blood-brain barrier in obesity is acquired and reversible.

Authors:  William A Banks; Catherine L Farrell
Journal:  Am J Physiol Endocrinol Metab       Date:  2003-03-04       Impact factor: 4.310

6.  Passage of vasoactive intestinal peptide across the blood-brain barrier.

Authors:  Dilek Dogrukol-Ak; William A Banks; Nese Tuncel; Muzaffer Tuncel
Journal:  Peptides       Date:  2003-03       Impact factor: 3.750

7.  Developmentally regulated mannose 6-phosphate receptor-mediated transport of a lysosomal enzyme across the blood-brain barrier.

Authors:  Akihiko Urayama; Jeffrey H Grubb; William S Sly; William A Banks
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-16       Impact factor: 11.205

8.  Transport of alpha-aminoisobutyric acid across brain capillary and cellular membranes.

Authors:  R G Blasberg; J D Fenstermacher; C S Patlak
Journal:  J Cereb Blood Flow Metab       Date:  1983-03       Impact factor: 6.200

9.  Measurement of protein using bicinchoninic acid.

Authors:  P K Smith; R I Krohn; G T Hermanson; A K Mallia; F H Gartner; M D Provenzano; E K Fujimoto; N M Goeke; B J Olson; D C Klenk
Journal:  Anal Biochem       Date:  1985-10       Impact factor: 3.365

Review 10.  Lipid modification of proteins and their membrane transport.

Authors:  A V Kabanov; A V Levashov
Journal:  Protein Eng       Date:  1989-10
View more
  31 in total

1.  Nanomedicine in the diagnosis and therapy of neurodegenerative disorders.

Authors:  A V Kabanov; H E Gendelman
Journal:  Prog Polym Sci       Date:  2007       Impact factor: 29.190

2.  Active Targeted Macrophage-mediated Delivery of Catalase to Affected Brain Regions in Models of Parkinson's Disease.

Authors:  Yuling Zhao; Matthew J Haney; Vivek Mahajan; Benjamin C Reiner; Anna Dunaevsky; R Lee Mosley; Alexander V Kabanov; Howard E Gendelman; Elena V Batrakova
Journal:  J Nanomed Nanotechnol       Date:  2011-09-10

3.  Exosomes as drug delivery vehicles for Parkinson's disease therapy.

Authors:  Matthew J Haney; Natalia L Klyachko; Yuling Zhao; Richa Gupta; Evgeniya G Plotnikova; Zhijian He; Tejash Patel; Aleksandr Piroyan; Marina Sokolsky; Alexander V Kabanov; Elena V Batrakova
Journal:  J Control Release       Date:  2015-03-31       Impact factor: 9.776

4.  Polyelectrolyte complex optimization for macrophage delivery of redox enzyme nanoparticles.

Authors:  Yuling Zhao; Matthew J Haney; Natalia L Klyachko; Shu Li; Stephanie L Booth; Sheila M Higginbotham; Jocelyn Jones; Matthew C Zimmerman; R Lee Mosley; Alexander V Kabanov; Howard E Gendelman; Elena V Batrakova
Journal:  Nanomedicine (Lond)       Date:  2011-01       Impact factor: 5.307

Review 5.  Nanotools for megaproblems: probing protein misfolding diseases using nanomedicine modus operandi.

Authors:  Vladimir N Uversky; Alexander V Kabanov; Yuri L Lyubchenko
Journal:  J Proteome Res       Date:  2006-10       Impact factor: 4.466

Review 6.  Strategies to improve drug delivery across the blood-brain barrier.

Authors:  Albertus G de Boer; Pieter J Gaillard
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

Review 7.  Novel nanomaterials for clinical neuroscience.

Authors:  Jamie L Gilmore; Xiang Yi; Lingdong Quan; Alexander V Kabanov
Journal:  J Neuroimmune Pharmacol       Date:  2008-01-22       Impact factor: 4.147

8.  A macrophage-nanozyme delivery system for Parkinson's disease.

Authors:  Elena V Batrakova; Shu Li; Ashley D Reynolds; R Lee Mosley; Tatiana K Bronich; Alexander V Kabanov; Howard E Gendelman
Journal:  Bioconjug Chem       Date:  2007-08-31       Impact factor: 4.774

9.  The utilization of pathogen-like cellular trafficking by single chain block copolymer.

Authors:  Gaurav Sahay; Vivek Gautam; Robert Luxenhofer; Alexander V Kabanov
Journal:  Biomaterials       Date:  2009-12-05       Impact factor: 12.479

10.  Transport across the blood-brain barrier of pluronic leptin.

Authors:  Tulin O Price; Susan A Farr; Xiang Yi; Serguei Vinogradov; Elena Batrakova; William A Banks; Alexander V Kabanov
Journal:  J Pharmacol Exp Ther       Date:  2010-01-06       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.